论文部分内容阅读
OBJECTIVE According to the feature that Trimebutine Maleate has poor aqueous solubility, low bioavailability when taken orally, short biological half-life(2.7h), sustained-release dropping pills were prepared to achieve release slowly, reduce the blood drug concentration fluctuations and decrease frequency of use.